CPIC 2026 | What determines the pricing of innovative drug BD in China?

Jul 30,2026

Maximizing the Value of Innovative Drugs in China

CPIC 2026 | Ma Jun: Where has China CGT gone?

Jul 29,2026

For the Chinese cell gene therapy industry, it is a node that connects the past and opens up the future.

Tonacea Launches Self-Discipline Convention Endorsed by Over 100 CGT Companies

Jul 28,2026

Taking events as a mirror and promoting development through self-discipline

Dialogue with Zhu Yi: Whatever Keytruda Can Sell, We Can Sell Too

Jul 25,2026

One dares to ask, the other dares to answer.

Daniel Mathews represented EY at the main forum and released a white paper.

Jul 23,2026

bringing more treatment options to patients worldwide.
< 1234...26 > proceed page